. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 2006; 75: 222-66.
. Cao P, Abedini A, Raleigh DP. Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology Curr. Opin. Struct. Biol. 2013; 23: 82-9.
. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJ, McFarlane HT, Madsen A, Riekel C, Eisenberg D. Atomic structures of amyloid cross-beta spines reveal varied steric zippers Nature. 2007; 447: 453-7.
. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002; 297: 353-6.
. Hamley IW. The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization. Chem Rev. 2012; 112: 5147-92.
. Soto C, Saborio GP, Permanne B. Inhibiting the conversion of soluble amyloid-beta peptide into abnormally folded amyloidogenic intermediates: relevance for Alzheimer’s disease therapy. Acta Neurol Scand Suppl. 2000; 176: 90-5.
. Gazit E. A possible role for pi-stacking in the self- assembly of amyloid fibrils. FASEB J. 2002; 16: 77-83.
. Reinke AA, Gestwicki JE. Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des. 2007; 70: 206-15.
. Porat Y, Abramowitz A, Gazit E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des. 2006; 67: 27-37
. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, et al. Curcumin structure function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. J Pharmacol Exp Ther. 2008; 326: 196-208
. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280(7): 5892-901.
. Ramshini H, mohammad-zadeh M, Ebrahim-Habibi A. Inhibition of amyloid fibril formation and cytotoxicity by a chemical analog of Curcumin as a stable inhibitor. Int J Biol Macromol. 2015;78: 396-404.
. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta, Neuron. 2008; 59: 43-55.
. Mandel SA, Amit T, Kalfon L, Reznichenko L, Weinreb O, Youdim MB. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG), J. Alzheimers Dis. 2008; 15: 211-22.
. Garbe TR, Kobayashi M, Shimizu N, Takesue N, Ozawa M, Yukawa H. Indolyl carboxylic acids by condensation of indoles with a-keto acids, J. Nat. Prod. 2000; 63: 596-598.
. Ramshini H, Ebrahim-Habibi A. Thermal disaggregation of type B yeast hexokinase by indole derivatives: a mechanistic study Int J Biol Macromol. 2012 Jun 1; 50(5): 1260-6.
. Ramshini H, Mannini B, Khodayari K, Ebrahim-Habibi A, Moghaddasi AS, Tayebee R, et al. Bis (indolyl) phenylmethane derivatives are effective small molecules for inhibition of amyloid fibril formation by hen lysozyme Eur J Med Chem. 2016; 29: 361-71.
. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods. 1983; 65: 55-63.
. Armstrong AH, Chen J, McKoy AF, Hecht MH. Mutations that replace aromatic side chains promote aggregation of the Alzheimer’s Abeta peptide. Biochemistry. 2011; 50: 4058-67.
. LeVine III H. Small molecule inhibitors of Abeta assembly, Amyloid. 2007; 14: 185-97.
. Chiti F, Taddei N, Stefani M, Dobson CM, Ramponi G. Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation, Protein Sci. 2001; 10: 879-86.
. Burley SK, Petsko GA. Aromatic-aromatic interaction: a mechanism of protein structure stabilization, Science. 1985; 229: 23-8.
. Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, et al. Green tea epigallocatechin-3-gallate (EGCG) reduces beta amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice, Brain Res. 2008; 1214: 177-87.
. Ladiwala AR, Dordick JS, Tessier PM. Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways, J. Biol. Chem. 2011; 286: 3209-18.
. Cohen T, Frydman-Marom A, Rechter M, Gazit E. Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives, Biochemistry. 2006; 45: 4727-35.
. Bendheim PE, Poeggeler B, Neria E, Ziv V, Pappolla MA, Chain DG. Development of indole-3-propionic (oxigon) for Alzheimer's disease, J. Mol. Neurosci. 2002; 19: 213-7.